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CHAPTER 1                                                                   INTRODUCTION  
1. INTRODUCTION
The quality of a drug plays an important role in ensuring the safety and
efficacy  of  the  drugs.  Quality  assurance  and  control  of  pharmaceutical  and
chemical  formulations  is  essential  for  ensuring  the  availability  of  safe  and
effective  drug  formulations  to  consumers.  Hence  Analysis  of  pure  drug
substances and their pharmaceutical  dosage forms occupies a pivotal  role in
assessing the suitability to use in patients.  The quality of the analytical data
depends  on the quality  of  the  methods employed  in  generation of  the data.
Hence, development of rugged and robust analytical methods is very important
for statutory certification of drugs and their formulations with the regulatory
authorities.[1]
The wide variety of  challenges are encountered while developing the
methods for different drugs depending on its nature and properties. This along
with  the  importance  of  achieving  the  selectivity,  speed,  cost,  simplicity,
sensitivity,  reproducibility  and  accuracy  of  results  gives  an  opportunity  for
researchers to come out with solution to address the challenges in getting the
new methods of  analysis  to  be adopted by the  pharmaceutical  industry  and
chemical laboratories.
1.1.ANALYTICAL METHODS
Analytical methods are defined as the set of techniques that allow us to 
determine qualitatively and / or quantitatively the composition of any material 
and chemical state in which it is located.[1]
Different physico-chemical methods are used to study the physical 
phenomenon that occurs as a result of chemical reactions.
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Chemical methods:
The chemical methods include the gravimetric and volumetric procedures 
which are based on complex formation; acid-base, precipitation and redox 
reactions. Titrations in non-aqueous media and complexometry have also been 
used in pharmaceutical analysis.[2]
Instrumental (Physical methods) :
  Table. No. 1.1. Classification of Instrumental methods
S.NO Method Examples
1. Electrochemical methods [2] Potentiometry
Conductometry
Electrogravimetry
Polarography
Coulometry
2. Optical methods Atomic absorption
spectroscopy
Raman spectroscopy
Emission spectroscopy
Refractometry
Absorption
spectrophotometry
Turbidimetry
Nephelometry  
Luminescence analysis
X-Ray spectroscopy
3. Radiometric methods Isotopic dilution
4. Mass spectroscopy
5. Nuclear magnetic resonance
6. Chromatography
(separation and analytical method)
Thin layer Chromatography
Paper Chromatography
Column Chromatography
High Performance Liquid
Chromatography
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Ion Exchange
Chromatography
Gas Chromatography
1.2 CHROMATOGRAPHY 
Chromatography (Chroma means ‘color’ and graphein means to ‘write’) is the
collective term for a set of laboratory techniques for the separation of mixtures.
It involves passing a mixture dissolved in a "mobile phase" through a stationary
phase, which separates the analyte to be measured from other molecules in the
mixture based on differential partitioning between the mobile and stationary
phases.[3] 
             Table. No.1. 2.Different types of chromatographic techniques
S. No Basic principle involved Type of Chromatography
1.      Techniques by         chromatographic bed 
shape
Column chromatography
Paper chromatography
Thin layer chromatography
2 Techniques by physical state of mobile 
phase
Gas chromatography
Liquid chromatography
3 Affinity chromatography Supercritical fluid chromatography
4 Techniques by separation mechanism Ion exchange chromatography
Size exclusion chromatography
5 Special techniques Reversed phase chromatography
Simulated moving-bed 
chromatography
Pyrolysis gas chromatography
Fast protein liquid chromatography
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Counter current chromatography
Chiral chromatography
1.3.HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
The modern form of column chromatography has been called high performance, high 
pressure, high-resolution and high-speed liquid chromatography.
 High-Performance Liquid Chromatography (HPLC) is a special branch of column 
chromatography in which the mobile phase is forced through the column at high 
speed.  As a result the analysis time is reduced by 1-2 orders of magnitude relative to 
classical column chromatography and the use of much smaller particles of the 
adsorbent or support becomes possible which increase the column efficiency 
substantially.[4]  
CLASSIFICATION OF HPLC
         Table. No. 1.3.Classification of Chromatography [4]
     Sl. No   Type of Chromatography
1 Modes of Chromatography
Normal  phase Chromatography
Reverse phase Chromatography
2 Principle of separation
Adsorption Chromatography
Partition  Chromatography
Ion exchange Chromatography
Size exclusion Chromatography
Affinity Chromatography
Chiral phase Chromatography
3 Elution Technique
Isocratic Separation
Gradient Separation
4 Scale of Operation
Analytical HPLC
Preparative HPLC
5 Type of Analysis
Qualitative Analysis
Quantitative Analysis
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Partition chromatography
This method results  from a thermodynamic distribution of analytes  between
two liquid    phases. On the basis of relative polarities of stationary and mobile
phase, partition chromatography can be divided into normal phase and reverse
phase chromatography.
Normal  Phase  -  High  Performance  Liquid  Chromatography  (NP-
HPLC)
In Normal phase HPLC the stationary phase is polar and mobile phase is non-
polar.  Common  solvents  (such  as  hexane,  heptanes,  etc.)  with  the  small
addition of polar modifier (i.e., methanol, ethanol) are generally used. Packing
materials  traditionally  used in  NP-HPLC are  usually  porous  oxides  such as
silica (SiO2) or alumina (Al2O3). Surface of these stationary phases is covered
with the dense population of OH groups, which makes these surfaces highly
polar. Chemically modified stationary phases can also be used in NP-HPLC.
Silica modified with trimethoxy glycidoxypropyl silanes (common name: diol-
phase) is typical packing material with decreased surface polarity. Since NP-
HPLC uses mainly non-polar solvents, it  is the method of choice for highly
hydrophobic compounds (which may show very stronger interaction with non
polar mobile phases), which are insoluble in polar or aqueous solvents.[5]
Reversed Phase - High Performance Liquid Chromatography (RP-
HPLC)
As  opposed  to  NP-HPLC,  RP-HPLC  employs  mainly  dispersive  forces
(hydrophobic  or  vanderwal’s  interactions).  The  polarities  of  mobile  and
stationary phases are reversed, such that the surface of the stationary phase in
RP-HPLC is hydrophobic and mobile phase is polar, where mainly water-based
solutions  are  employed.  RP-HPLC  is  by  far  the  most  popular  mode  of
chromatography. Almost 90% of all analyses of low-molecular-weight samples
are carried out using RP-HPLC. Dispersive forces employed in this separation
mode  are  the  weakest  intermolecular  forces,  thereby  making  the  overall
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background  interaction  energy  in  the  chromatographic  system  very  low
compared to other separation techniques. This low background energy allows
for distinguishing very small  differences in molecular interactions of closely
related  analytes.  Adsorbents  employed  in  this  mode  of  chromatography  are
porous  rigid  materials  with  hydrophobic  surfaces.  The  majority  of  packing
materials used in RP-HPLC are chemically modified porous silica.[5]
Adsorption chromatography
The analyte interact with solid stationary surface and are displaced with eluent
for active sites on surface.
Ion exchange chromatography (IEC)
IEC  is  based  on  the  differences  in  affinities  of  the  analyte  ions  for  the
oppositely charged ionic center  in the resin or adsorbed counter ions in the
hydrophobic stationary phase. Consider the exchange of two ions  A+ and  B+
between the solution and exchange resin E−:
A·E + B+ ↔B·E + A+
This essentially determines the relative affinity of both cations to the exchange
centers on the surface. If the constant is equal to 1, no discriminating ability is
expected for this system.Four major types of ion-exchange centers are usually
employed [6]:
• SO3-—strong cation-exchanger
• CO2-—weak cation-exchanger
• Quaternary amine—strong anion-exchanger
• Tertiary amine—weak anion-exchanger
Analyte retention and selectivity in ion exchange chromatography are strongly
dependent on the pH and ionic strength of the mobile phase. 
Size exclusion chromatography (SEC):
SEC is the method for dynamic separation of molecules according to their size.
The separation is  based on the  exclusion of  the molecules  from the porous
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space of packing material due to their steric hindrance. Hydrodynamic radius of
the analyte molecule is the main factor in determining its retention. This is the
only chromatographic separation method where any positive interaction of the
analyte with the stationary phase should be avoided. 
In  SEC,  the  higher  the  molecular  weight  of  the  molecule,  the  greater  its
hydrodynamic radius results in faster elution. [6]
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INSTRUMENTATION OF HPLC
HPLC is a special  branch of Column Chromatography in which the mobile
phase is forced through the column at high speed. As a result, the analysis time
is  reduced  by  1-2  orders  of  magnitude  relative  to  classical  Column
chromatography  and  the  use  of  much  smaller  particles  of  the  absorbent  or
support becomes possible increasing the column efficiency substantially[7]. The
basic HPLC Instrumentation  is shown in the Fig. No. 1.1
Figure  .1.1.  Instrumentation  of  a  High  Performance  Liquid
Chromatography.      
(1) Solvent reservoirs,                                        (6) Switching valve in "inject
position",
(2) Solvent degasser,                                           (7) Sample injection loop,
(3) Gradient valve,                                               (8) Pre-column or guard column
(4) Mixing vessel for delivery of the                     (9) Analytical column,
mobile phase,                                                       (10) Detector (i.e. IR, UV),
(5) High-pressure pump ,                                      (11) Data acquisition,
 (6') Switching valve in "load position",               (12) Waste or fraction collector.
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i.Solvent delivery system:  
The most  important  component  of  HPLC in  solvent  delivery  system is  the
pump,  because  its  performance  directly  effects  the  retention  time,
reproducibility  and  detector  sensitivity.  Among  the  several  solvent  delivery
systems,  (direct  gas  pressure,  pneumatic  intensifier,  reciprocating  etc.)
reciprocating pump with twin or triple pistons is widely used, as this system
gives less baseline noise, good flow rate reproducibility etc.
The pumping systems used in HPLC can be categorized in three different ways.
 The first classification is according to the eluent flow rate that the pump
is capable of delivering: Standard bore systems, Micro bore systems
 The second classification  is  according  to  the  construction  materials  :
Metallic, non-metallic
 The final  classification is  according to  the mechanism by which the
pump  delivers  the  eluent  :  syringe  pumps  and  reciprocating-piston
pump. 
  ii.Solvent degassing system
  The constituents of the mobile phase should be degassed and filtered before
use. Several   methods can be applied to remove the dissolved gases in the
mobile phase. They include 
 heating and stirring, 
 filtration through 0.45µm filters, 
 vacuum degassing with an air-soluble membrane, 
 Helium purging ultra signification or purging or combination of these
methods. 
 HPLC systems  are  also  provided  an online  degassing  system which
continuously removes the dissolved gases from the mobile phase.[8]
  iii.Sample introduction system:
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Two means for analyte introduction on the column are injection into a flowing
stream and a stop flow injection. These techniques can be used with a syringe
or an injection valve. Automatic injector is a microprocessor-controlled version
of the manual universal injector. 
Injector
Injectors should provide the possibility of injecting the liquid sample within
the range  of 0.1 to 100 ml of volume with high reproducibility and under high
pressure  (up  to  the  4000  psi).  They  should  also  produce  minimum  band
broadening  and  minimize possible  flow  disturbances.  The  most  useful  and
widely used sampling device for modern LC is the  micro sampling injector
valve.  With these sampling  valves,  samples  can be introduced reproducibly
into  pressurized  columns  without  significant  interruption  of  flow  even  at
elevated temperatures.[9] 
                        LOAD (the sample loop)                                  INJECT (move the
sample loop 
                                                                                                       In the mobile phase
Fig. No.1.2 .Injection system
iv.Columns
The heart of the system is the column. Analytical column is the most important
part of the HPLC which decides the efficiency of separation.  The choice of
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common  packing  material  and  mobile  phases  depends  on  the  physical
properties of the drug.[9] 
The following properties of  the column stationary phases play an important
role in giving different selectivity for separations.
i)  Particle size,  ii)  Particle  shape,  iii)  Pore size /  Pore volume,  iv) Specific
surface area,  v) End capping, vi) % carbon loading.
The following are the most widely used  columns with stationary phases for 
separation and quantification of wide variety of drugs.
i). Silica based columns with different bonding phases like C4, C6, C8, C18,
C20 and bonding phases having functional groups like cyano, phenyl, naphthyl
and amino.
ii). Silica based columns with polar embedded phases within chains of C8, 
C18, NH2.
iii). Strong cation exchange (SCX) and strong anion exchange (SAX) columns.
iv). Size Exclusion chromtography (SEC) or gel permeation chromatography 
(GPC) columns. 
v). Silica based monolith columns.
vi). Fused core silica columns with bonding phases like C8, C18,
CN, phenyl. 
vii). Metal oxide columns like zirconia based and alumina based.
viii). Chiral columns.
Column-packing materials 
Silica (SiO2.X H2O) is the most widely used substance for the manufacture of
packing materials  it  consist  of  a network of  siloxane linkages(Si-O-Si)  in a
rigid three dimensional  structure containing inter connected pores.[10] Thus a
wide range of commercial  products are available with surface areas ranging
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from 100 to 800 m2/g and particle sizes from 3 to 50 µm. The silonol groups on
the surface of silica give it a polar character, which is exploited in adsorption
chromatography  using  non-polar  organic  elutents.  Silica  can  be  drastically
altered by reaction with organochlorosilanes or organoalkoxysilanes giving Si-
O-Si-R  linkages  with  the  surface.  The  attachment  of  hydrocarbon  chain  to
silica produces a non polar surface suitable for reversed phase chromatography
where mixtures of water and organic solvents are used as eluents. The most
popular  material  is  octa  decyl  silica  (ODS)  which  contains  C18chains,  but
material with C2, C6, C8 and C22 chains are also available. 
The most popular brands of LC columns:
 Inertsil, Hypersil, X-terra, X-bridge, Sun-fire, Atlantis, Aquity-BEH, Zorbax,
Lichrosphere, Purosphere, Sperisorb, Luna, Kromasil, ACE, YMC, Symmetry,
Chiralcel and Chiralpak. 
The LC columns are supplied in different dimensions: 
Column lengths - 10 mm, 50 mm, 100mm, 150mm, 250mm, 300mm, 500mm
and  Internal diameters -2.1mm, 3.0mm, 4.0mm, 4.6mm. 
LC columns with stationary phases having different particle sizes like 5.0 µm,
4.0 µm 3.5 µm, 3.0 µm, 2.5 µm, 2.0 µm, 1.9 µm, 1.8 µm, 1.7 µm and 1.3 µm
are available.
V.Mobile phase
Mobile phases used for HPLC are typically mixtures of organic solvents and
water or aqueous buffers.
The following points should also be considered when choosing a mobile
phase:
 It is essential to establish that the drug is stable in the mobile phase for at
least the duration of the analysis. 
 Excessive salt  concentrations  should be avoided.  High salt  concentrations
can result in precipitation which can damage HPLC equipment.
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Reduce cost and toxicity of the mobile phase by using methanol instead 
of acetonitrile whenever possible.
 Minimize the absorbance of buffer. Since trifluroacetic acid or formic acid
absorb  at  shorter  wavelengths.  They  may  prevent  detection  of  products
without  chromophores  above  220 nm.  Carboxylic  acid  modifiers  can be
frequently replaced by phosphoric acid which does not absorb above 200
nm.[11]  
Physical properties of some HPLC solvents were summarized in Table: 1.4 
Table No. 1.4. Physical properties of common HPLC solvents
Solvent MW BP
RI
(25 oC)
UV
Cut-
off
(nm)
Density
g / ml
(25 oC)
Viscosity
cP
(25 oC)
Dielectric
Constant
Acetonitrile 41.0 82 1.342 190 0.787 0.358 38.8
Dioxane 88.1 101 1.420 215 1.034 1.26 2.21
Ethanol 46.1 78 1.359 205 0.789 1.19 24.5
Ethyl 
acetate 88.1 77 1.372 256 0.901 0.450 6.02
Methanol 32.0 65 1.326 205 0.792 0.584 32.7
CH2Cl2 84.9 40 1.424 233 1.326 0.44 8.93
Isopropano
l 60.1 82 1.375 205 0.785 2.39 19.9
n-propanol 60.1 97 1.383 205 0.804 2.20 20.3
THF 72.1 66 1.404 210 0.889 0.51 7.58
Water 18.0 100 1.333 170 0.998 1.00 78.5
Vi. Detectors 
The detection of UV light absorbance offers both convenience and sensitivity
for molecules. When a chromophore is present, the wavelength of detection for
a drug should be based on its UV Spectrum in the mobile phase and not in pure
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solvents. The most selective wavelength for detecting a drug is frequently the
longest ⋋max  to avoid interference from solvents, buffers and excipients. Other
methods of detection can be useful are required in some instances.
• Solute specific detectors (UV-Vis, fluorescence, infra-red, radio activity)
• Bulk property detectors (refractive index, viscometer, conductivity)
• Desolvation detectors (flame ionization etc.)
• LC-MS detectors
• Reaction detectors
Applications of HPLC in pharmaceutical research :
• Separation:  This can be accomplished using HPLC by utilizing the fact
that, certain compounds have different  migration rates given a particular
column and mobile phase. The extent or degree of separation is determined
by the choice of stationary phase and mobile phase along with parameters
like flow, temperature and gradient programme. 
• Identification: For this purpose a clean peak of known sample has to be
observed from the chromatogram. Selection of column mobile phase and
flow rate matter to certain level in this process. Identification is generally by
comparing with reference compound based on retention time and also based
on  UV-Vis  spectra  in  some  cases.  Identification  can  be  assured  by
combining two or more detection methods, where necessary. 
• Quantification:  Analyte  concentrations  are  estimated  by  measuring  the
responses  (peak areas) known reference standards  followed by unknown
samples. Quantification of known and unknown components are done by
various  methods  like  -  area  normalization  method,  internal  standard
method, external standard method and diluted standard method along with
relative response factors. 
• Isolation  :  It  refers  to  the  process  of  isolation  and  purification  of
compounds  using analytical  scale  or  preparative  scale  HPLC.  Volatile
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buffers and solvents are preferred choice as mobile phases as it reduces the
effort on purification. Solute purity and throughput is the key challenge in
isolation and purification processes.
HPLC theory: 
The theory of chromatography has been used as the basis for system- suitability
tests,  which  are  set  of  quantitative  criteria  that  test  the  suitability  of  the
chromatographic  system  to  identify  and  quantify  drug  related  samples  by
HPLC at any step of the pharmaceutical analysis. 
 Retention time (tR), capacity factor k' and relative retention time (RRT)
The time  elapsed  between  the  injection  of  the  sample  components  into  the
column and  their detection is known as the retention time (tR).   The retention
time is longer when the solute has higher affinity to the stationary phase due to
its chemical nature.  For example, in reverse phase chromatography, the more
lyophilised compounds are retained longer.  Therefore, the retention time is a
property of the analyte that can be used for its identification. A non retained
substance  passes  through  the  column  at  a  time  t0,  called  the  void  time. 
Retention factor is calculated as follows:
Fig. No.1.3. Figure showing retention factor
The capacity factor describes the thermodynamic basis of the separation
and its definition is the ratio of the amounts of the solute at the stationary and
mobile  phases  within  the  analyte  band  inside  the  chromatographic  column:
Where Cs is the concentration of the solute at the stationary phase and Cm is its
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concentration at  the mobile  phase  and phi is  the ratio  of the  stationary and
mobile  phase  volumes  all  within  the  chromatographic  band.  The  Retention
Factor is  used  to  compare  the  retention  of  a  solute  between  two
chromatographic systems, normalizing it to the column's geometry and system
flow rate. The retention factor value should be in between 1-20.[11] 
Efficiency: Plate count N and peak capacity Pc:
The efficiency of the separation is determined by the plate count N when
working  at  isocratic  conditions,  whereas  it  is  usually  measured  by  Peak
Capacity Pc when working at gradient conditions. The following equation for
the plate count is used by the United States Pharmacopoeia (USP) to calculate
N:
Fig. No.1.4. Figure showing Number of Theoretical Plates
 Where  w is  measured  from the  baseline  peak  width  calculated  using  lines
tangent  to  the  peak  width  at  50  %  height. European  and  Japanese
pharmacopoeias  use  the  peak  width  at  50% of  the  peak  height,  hence  the
equation becomes:
 Peak capacity Pc is defined as number of peaks that can be separated within a
retention window for a specific pre-determined resolution. In other words, it is
the runtime measured in peak width units .   It is assumed that peaks occur over
the gradient chromatogram. Therefore,  peak capacity can be calculated from
the peak widths in the chromatogram as follows:
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 Where n is the number of peaks at the segment of the gradient selected for the
calculation, tg. Thus peak capacity can be simply the gradient run time divided
by  the  average  peak  width.   The  sharper  the  peaks  the  higher  is  the  peak
capacity, hence the system should be able to resolve more peaks at the selected
run time as well as detect lower concentrations.
Another  measure  of  the  column's  chromatographic  efficiency  is  the  height
equivalent to theoretical plate (HETP) which is calculated from the following
equation:
HETP = (L/N)
 Where L is column length and N is  the plate count.  HETP is measured in
micrometer.  
The behaviour of HETP as function of linear velocity has been described by
various equations. It is frequently called "The Van-Deemter curve", and it is
frequently  used  to  describe  and  characterize  various  chromatographic
stationary phases' performance and compare them to each other. The lower are
the values of HETP, the more efficient is the chromatographic system, enabling
the detection of lower concentrations due to the enhanced signal-to-noise ratio
of all the peaks in the chromatogram. 
Peak asymmetry factor Af and tailing factor T:
 The chromatographic peak is assumed to have a gaussian shape under ideal
conditions, describing normal distribution of the velocity of the molecules
populating the peak zone migrating through the stationary phase inside the
column.  Any deviation from the normal distribution indicates non-ideality
of the distribution and the migration process therefore might jeopardize the
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integrity  of  the  peak's  integration,  reducing  the  accuracy  of  the
quantitation.  This  is  the reason why USP Tailing  is  a  peak's  parameter
almost always measured in the system suitability step of the analysis.[12]  
 The deviation from symmetry is measured by the asymmetry factor, Af  or 
tailing factor  T.  The calculation of  asymmetry factor, Af   is described by
the following equation:
Fig. No.1.5. Figure showing Asymmetric Factor
 Where  A and  B are sections  in the  horizontal  line parallel  to the  baseline,
drawn at 10% of the peak height. The calculation of tailing Factor, T, which is
more  widely  used  in  the  pharmaceutical  industry,  as  suggested  by  the
pharmacopeia’s, where A and B are sections in the horizontal line parallel to
the baseline, drawn at 5% of the peak height.  The USP suggests that  tailing
factor should be in the range of 0.5 up to 2 to assure a precise and accurate
quantitative measurement.  
Selectivity Factor Alfa and Resolution Factor Rs:
The separation is a function of the thermodynamics of the system. Substances
are separated in a chromatographic column when their rate of migration differs,
due to their different distribution between the stationary and mobile phases. 
The  selectivity  factor,  α,  and  resolution  factor,  Rs,  measure  the  extent  of
separation between two adjacent peaks.  The  selectivity factor accounts only
for the ratio of the retention factors,  k', of the two peaks (k'2/k'1), whereas the
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resolution factor, Rs, accounts for the difference between the retention times of
the two peaks relative to their width
 Fig. No.1.6. Figure showing Resolution Factor
The equation that  describes  the experimental  measurement  of  the  resolution
factor, Rs, is as follows:                                      Rs = ∆tR / 0.5 (W1 + W2)
Where  tR is  the retention time of peaks 1 and 2 respectively and  w is  their
respective peak width at the tangents  baseline.  According to the pharmacopeia
value should be above 1.5 for an accurate quantitative measurement.   
                    
Fig. No.1.7. Figure showing selectivity
It  can  be  clearly  seen  from  this  equation  that  the  plate  count  is  the  most
effecting parameter in the increase of the chromatographic resolution.  Since
the plate count increases with the reduction in particle diameter, it explains the
reduction in particle diameter of the stationary phase material during the last 3
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decades of HPLC.  This is also the rational behind the recent trend in HPLC,
the use of sub 2 micron particle columns and the development of a specially
design of ultra performance HPLC systems to accommodate such columns.[12]
1.4..ANALYTICAL METHOD DEVELOPMENT
Methods  are  developed  for  new  products  when  no  official  methods  are
available.  Alternate methods for existing (Non-Pharmacopoeias) products are
developed to reduce the cost and time for better precision and ruggedness. Trial
runs are conducted, method is optimized and validated. When alternate method
proposed is intended to replace the existing procedure, comparative laboratory
data including merits / demerits should be made available
Steps involved in method development
Documentation starts at the very beginning of the development process. 
1. Analyte standard characterization
a) All known information about the analyte and its structure is collected i.e.,
physical and chemical properties.
b) The standard analyte (100 % purity) is obtained.  Necessary arrangement is
made for the proper storage (refrigerator, desiccators and freezer).
c) When multiple  components  are  to  be  analyzed  in  the  sample  matrix,  the
number of components is noted, data is assembled and the availability of
standards for each one is determined.
d) Only  those  methods  (spectroscopic,  MS,  GC,  HPLC  etc.,)  that  are
compatible with sample stability are considered.
2. Method requirements
The goals or requirements of the analytical method that need to be developed
are considered and the analytical  figures of merit  are defined.  The required
detection  limits,  selectivity,  linearity,  range,  accuracy  and  precision  are
defined.[13] 
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3. Literature search and prior methodology
The  literature  for  all  types  of  information  related  to  the  analyte  is
surveyed.  solubility  profile  (solubility  of  Drug  in  different  solvents  and  at
different pH conditions),  analytical  profile (Physico-chemical  properties,  Eg:
pKa, melting point, degradation pathways, etc) and stability profile (sensitivity
of the drug towards light, heat, moisture etc) and relevant analytical methods,
books, periodicals, chemical manufacturers and regulatory agency compendia
such as USP / NF, are reviewed.
 
4. Choosing a method
a) Using the information in the literatures and prints, methodology is adopted.
The methods are modified wherever necessary. Sometimes it is necessary to
acquire additional instrumentation to reproduce, modify, improve or validate
existing methods for in-house analytes and samples.
b) If there are no prior methods for the analyte in the literature, from analogy,
the  compounds  that  are  similar  in  structure  and  chemical  properties  are
investigated and are worked out. There is usually one compound for which
analytical method already exist that is similar to the analyte of interest.
c) 5. Instrumental setup and initial studies
The required instrumentation is setup. Installation, operational and performance
qualification of instrumentation using laboratory standard operating procedures
(SOP’s) are verified. Always new consumables (e.g. solvents, filters and gases)
are  used.  For  example,  method  development  is  never  started  on  a  HPLC
column that has been used earlier. The analyte standard in a suitable injection /
introduction solution and in known concentrations and solvents are prepared. It
is  important  to  start  with  an  authentic,  known  standard  rather  than  with  a
complex sample matrix. If the sample is extremely close to the standard (e.g.,
bulk drug), then it is possible to start work with the actual sample.
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6. Optimization
During optimization one parameter is changed at a time and set of conditions
are isolated, rather than using a trial and error approach. Work has been done
from an organized methodical  plan,  and every step is documented (in a lab
notebook) in case of dead ends.         Table No.1.5-variables for improving
separation
Variable Comment
Choice of organic solvent A change from Methanol to Acetonitrile or THF
often results in large changes in separation .
Mobile phase pH A Change in pH may result in a major effect on
band spacing for samples that contain ionic or
ionisable compounds.
Solvent strength A change in percent organic often provides
significant changes in retention and separation.
Column type This refers to the choice of bonded-phases for
reversed-phase LC (C 18, C 8,Phenyl,cyano etc)
Concentration of mobile
phase additives
The most common additives for varying band
spacing include amine modifiers, acid modifiers,
buffers and salts.
Temperature The temperature can be varied between 0 to 70ºC
for the purpose of controlling band spacing;
however, temperatures of 25-60 ºC are more
common.
7. Documentation of analytical figures of merit
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The originally determined analytical figures of merit are limit of quantitation
(LOQ),  limit  of  detection  (LOD),  linearity,  time  per  analysis,  cost,  sample
preparation etc., are documented.
8. Evaluation of method development with actual samples
The sample solution should lead to unequivocal, absolute identification of the
analyte peak of interest apart from all other matrix components. 
9.Determination  of  percent  recovery  of  actual  sample  and
demonstration of quantitative sample analysis
Percent recovery of spiked, authentic standard analyte into a sample matrix that
is  shown to  contain  no analyte  is  determined.   Reproducibility  of  recovery
(average + / - standard deviation) from sample to sample and whether recovery
has been optimized or not has been shown. It is not necessary to obtain 100 %
recovery as long as the results are reproducible and known with a high degree
of  certainty.  The  validity  of  analytical  method  can  be  verified  only  by
laboratory studies. [13]            
                   Table No.1.6.Separation goals in HPLC method development 
Goal Comment
Resolution Precise and rugged quantitative analysis requires that Rs be
greater than 1.5.
Separation time <5-10 min is desirable for routine procedures.
Quantitation £2% for assays; £5% for less-demanding analyses ;
15% for trace analyses.
Pressure <150 bar is desirable, <200 bar is usually essential (new
column assumed).
Peak height Narrow peaks are desirable for large signal/noise ratios.
Solvent consumption Minimum mobile-phase use per run is desirable.
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METHOD DEVELOPMENT PROCEDURE
The wide variety of equipment’s, columns, eluent and operation preparations
involved  high  performance  liquid  chromatography  (HPLC)  method
development  seems  complex.  The  processes  influenced  by  the  nature  of
analytes and generally follow the following steps. [14]
Steps:
• Step 1 - Selection of the HPLC method and initial system 
• Step 2 - Selection of initial conditions 
• Step 3 - Selectivity optimization 
• Step 4 - System optimization 
• Step 5 - Method validation. 
HPLC method development
Step 1 - selection of the HPLC method and initial system.
               When developing an HPLC method, the first step is always to
consult the literature to ascertain whether the separation has been previously
performed  and  if  so,  under  what  conditions  -  this  will  save  time  doing
unnecessary experimental  work.  When selecting an HPLC system,  it  must
have  a  high  probability  of  actually  being  able  to  analyse  the  sample;  for
example,  if  the  sample  includes  polar  analytes  then  reverse  phase  HPLC
would offer  both adequate  retention and resolution,  whereas  normal  phase
HPLC  would  be  much  less  feasible.  Consideration  must  be  given  to  the
following: 
Sample preparation:
 Does  the  sample  require  dissolution,  filtration,  extraction,
preconcentration. 
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 Is  chemical  derivatization  required  to  assist  detection  sensitivity  or
selectivity 
Column dimensions:
For most samples (unless they are very complex), long columns (25 cm) are
recommended to enhance the column efficiency. A flow rate of 1-1.5 ml/min
should be used initially. packing particle size should be 3 or 5 µm. 
Detectors:
Consideration must be given to the following: 
• Do the analytes have chromophores to enable UV detection
• Is more selective/sensitive detection required
• What detection limits are necessary
• Will  the  sample  require  chemical  derivatization  to  enhance
detectability and/or improve the chromatography.
Fluorescence or electrochemical detectors should be used for trace analysis.
For preparative HPLC, refractive index is preferred because it can handle
high concentrations without over loading the detector.  UV wavelength for
the  greatest  sensitivity  λmax should  be  used,  which  detects  all  sample
components  that  contain  chromophores.  UV wavelengths  below 200  nm
should be avoided because detector noise increases in this region. Higher
wavelengths give greater selectivity. The excitation wavelength locates the
excitation  maximum;  that  is,  the  wavelength  that gives  the  maximum
emission  intensity.  The  excitation is  set  to  the  maximum value  then  the
emission is scanned to locate the emission intensity. Selection of the initial
system could, therefore, be based on assessment of the nature of sample and
analytes  together  with  literature  data,  experience,  expert  system software
and empirical approaches. 
  Step 2 - selection of initial conditions. 
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  This step determines the optimum conditions to adequately retain all analytes;
that is,        ensures no analyte has a capacity factor of less than 0.5 (poor
retention could result in peak overlapping) and no analyte has a capacity factor
greater than 10–15 (excessive retention leads to long analysis time and broad
peaks with poor detectability). Selection of the following is then required. 
Mobile phase solvent strength:
 The  solvent  strength  is  a  measure  of  its  ability  to  pull  analytes  from the
column. It is generally controlled by the concentration of the solvent with the
highest  strength;  for  example,  in  reverse  phase  HPLC with  aqueous mobile
phases,  the  strong  solvent  would  be  the  organic  modifier;  in  normal  phase
HPLC,  it  would  be  the  most  polar  one.  The  aim  is  to  find  the  correct
concentration of the strong solvent. With many samples, there will be a range
of  solvent  strengths  that  can be  used  within  the  a  fore  mentioned  capacity
limits. Other factors (such as pH and the presence of ion pairing reagents) may
also affect the overall retention of analytes. 
Step 3 - selectivity optimization:
             The aim of this step is to achieve adequate selectivity (peak spacing).
The mobile  phase  and  stationary phase  compositions  need to  be  taken into
account. To minimize the number of trial chromatograms involved, only the
parameters  that  are likely  to  have  a  significant  effect  on  selectivity  in  the
optimization must be examined. To select these, the nature of the analytes must
be considered. Once the analyte types are identified, the relevant optimization
parameters  may  be  selected.  Note  that  the  optimization  of  mobile  phase
parameters is always considered first as this is much easier and convenient than
stationary phase optimization. 
Step 4 - system parameter optimization:
             This is used to find the desired balance between resolution and analysis
time after satisfactory selectivity has been achieved. The parameters involved
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include column dimensions, column-packing particle size and flow rate. These
parameters may be changed without affecting capacity factors or selectivity. 
Step 5 - Method validation:
             Proper validation of analytical methods is important for pharmaceutical
analysis  when  ensure  of  the  continuing  efficacy  and  safety  of  each  batch
manufactured  relies  solely  on  the  determination  of  quality.  The  ability  to
control this quality is dependent upon the ability of the analytical methods, as
applied under well-defined conditions and at an established level of sensitivity,
to give a reliable demonstration of all deviation from target criteria. 
        Analytical methods should be used within good manufacturing practice
(GMP)  and  good  laboratory  practice  (GLP)  environments,  and  must  be
developed  using  the  protocols  set  out  in  the  international  conference  on
harmonization  (ICH)  guidelines  (Q2A  and  Q2B).  The  US  food  and  drug
administration  (FDA)  and  US  Pharmacopoeia  (USP)  both  refer  to  ICH
guidelines.  The  most  widely  applied  validation  characteristics  are  accuracy,
precision (repeatability and intermediate precision), specificity, detection limit,
quantitation  limit,  linearity,  range,  robustness  and  stability of  analytical
solutions. Method validation must have a written and approved protocol prior
to use.[14]
1.5.ANALYTICAL METHOD VALIDATION
Method validation can be defined as (ICH) 
“Establishing  documented  evidence,  which  provides  a  high  degree  of
assurance that a specific activity will consistently produce a desired result or
product meeting its predetermined specifications and quality characteristics”.
Method  validation  study  include  system  suitability,  linearity,  precision,
accuracy, specificity,  robustness, limit of detection, limit of quantification and
stability of samples, reagents, instruments.
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1. System Suitability
Prior to the analysis of samples of each day, the operator must establish that the
HPLC  system  and  procedure  are  capable  of  providing  data  of  acceptable
quality. This is accomplished with system suitability experiments, which can
be defined as tests to ensure that the method can generate results of acceptable
accuracy and Precision.  The requirements  for  system suitability  are  usually
developed after method development and validation have been completed.[15]  
       Table.No.1.7.System Suitability Parameters and Recommendations
PARAMETER RECOMMENDATION
Capacity Factor (k’) The peak should be well-resolved from
other peaks and the void  volume,
generally k’>2.0
Repeatability RSD </= 1% for N >/= 5 is desirable.
Resolution (Rs) Rs of > 2 between the peak of interest and
the closest eluting Potential interferent
(impurity, excipient, degradation product,
internal standard)
Theoretical Plates (N) In general should be > 2000
Tailing Factor (T) T of </= 2
2. Linearity
The  linearity  of  a  method  is  a  measure  of  how well  a  calibration  plot  of
response  vs.  concentration  approximates  a  straight  line.  Linearity  can  be
assessed by performing single measurements at several analyte concentrations.
The data is then processed using a linear least-squares regression. The resulting
plot slope, intercept and correlation coefficient provide the desired information
on linearity.  
3. Range
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The range is the interval between the upper and lower levels of the analytical
method that have been demonstrated to obtain acceptable level of precision,
accuracy and linearity.
                   Table.No.1.8. Range for the Analytical procedures
Analytical Procedure Range
Assay of a drug substance or a finished
product
80 to 120 % of the test concentration
Impurity(quantification) Reporting threshold to 120% of
Acceptance criteria
Assay and Impurity One test with 100% standard
Linearity: Reporting threshold to
120% assay  Acceptance criteria
content uniformity 70 to 130 %of the test  concentration
dissolution testing +/-20 % over the specified range
Drug release testing 20%  after 1 hour upto 90% after 24
hours
0-110% of label claim
4. Precision
Precision can be defined as “The degree of agreement among individual test
results  when the procedure is  applied repeatedly to multiple samplings  of  a
homogenous  sample”.  A  more  comprehensive  definition  proposed  by  the
International Conference on Harmonization (ICH) divides precision into three
types:
1. Repeatability
2. Intermediate precision and
3. Reproducibility
Repeatability is the precision of a method under the same operating conditions
over a short period of time.
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Intermediate precision is the agreement of complete measurements (including
standards)  when  the  same  method  is  applied  many  times  within  the  same
laboratory.
Reproducibility examines  the  precision  between  laboratories  and  is  often
determined in collaborative studies or method transfer experiments.
5. Accuracy
The accuracy of a measurement is defined as the closeness of the measured
value to the true value. In a method with high accuracy, a sample (whose “true
value” is known) is analyzed and the measured value is identical to the true
value. Typically, accuracy is represented and determined by recovery studies.
There are three ways to determine accuracy:
1. Comparison to a reference standard
2. Recovery of the analyte spiked into blank matrix or
3. Standard addition of the analyte.[15]
It should be clear how the individual or total impurities are to be determined.
e.g.,Weight  /  weight  or  area  percent  in  all  cases  with  respect  to  the  major
analyte.
6. Specificity / selectivity
The terms selectivity and specificity are often used interchangeably. According
to ICH, the term specific generally refers to a method that produces a response
for a single analyte  only while the term selective refers to a method which
provides responses for a number of chemical entities that may or may not be
distinguished from each other. If the response is distinguished from all other
responses, the method is said to be selective. Since there are very few methods
that  respond  to  only  one  analyte,  the  term  selectivity  is  usually  more
appropriate
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7. Robustness
The concept of robustness of an analytical procedure has been defined by the
ICH as “a measure of its capacity to remain unaffected by small, but deliberate
variations  in  method  parameters”.  A  good  practice  is  to  vary  important
parameters in the method systematically and measure their effect on separation.
The variable method parameters in HPLC technique may involves flow rate,
column temperature, sample temperature, pH and mobile phase composition.
8. Limit of detection
Limit of detection (LOD) is the lowest concentration of analyte in a sample
that  can  be  detected,  but  not  necessarily  quantitated,  under  the  stated
experimental  conditions.  Several  approaches  for  determining  the  LOD  are
possible,  depending  on  whether  the  procedure  is  a  non-instrumental  or
instrumental.
• Based on visual evaluation
• Based on signal-to-noise
• Based on the standard deviation of the response and the slope
The LOD may be expressed as:
LOD = 3.3 σ / S
Where, 
σ = Standard deviation of Intercepts of calibration curves
S = Mean of slopes of the calibration curves
The slope S may be estimated from the calibration curve of the analyte. 
9. Limit of quantification
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Limit of quantitation (LOQ) is the lowest concentration of analyte in a sample
that can be determined with acceptable precision and accuracy under the stated
experimental  conditions.  Several  approaches  for  determining  the  LOQ  are
possible  depending  on  whether  the  procedure  is  a  non-instrumental  or
instrumental.
• Based on visual evaluation
• Based on signal-to-noise Approach
• Based on the standard deviation of the response and the slope
The LOQ may be expressed as:
LOQ = 10 σ / S
Where, 
σ = Standard deviation of Intercepts of calibration curves
S = Mean of slopes of the calibration curves
The slope S may be estimated from the calibration curve of the analyte.[16] 
Table.No.1.9. Acceptance criteria of validation for HPLC
S.No Characteristics Acceptance criteria
1 Specificity No interference
2 Accuracy 98-102%
3 Precision RSD<2
4 Detection limit S/N > 2or 3
5 Quantitation limit S/N > 10
6 Linearity R2 > 0.999
7 Range 80-120%
10. Stability
To generate reproducible and reliable results, the samples, standards, and 
reagents used for the HPLC method must be stable for a reasonable time (e.g., 
one day, one week, one month, depending on need). Therefore, a few hours of 
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standard and sample solution stability can be required even for short (10 min) 
separation. When more than one sample is analyzed (multiple lots of one 
sample or samples from different storage conditions from a single lot), 
automated, overnight runs often are performed for better lab efficiency. Such 
practices add requirements for greater solution stability.  
Degradation studies:
Degradation studies or stress testing is conducted in order to investigate the
likely degradation products, which in turn helps to establish the degradation
pathways and the intrinsic stability of the drug molecule and also to provide
foundation for developing a suitable stability indicating method. Stress testing
the drug molecule under particular stress condition generate samples containing
degradation  products.  Use  these  samples  to  develop  suitable  analytical
methods.  The  degradation  products  generated  in  the  stressed  samples  are
termed as “potential”  degradation  products  that  may or  may not be  formed
under relevant storage conditions. Stress drug product, and placebo separately
to understand the peaks due to placebo components, if any. Four major forced
degradation studies are [17] 
(i) Thermolytic Degradation, 
(ii). Hydrolytic degradation, 
(iii). Oxidative degradation, 
(iv). Photolytic degradation. 
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2. LITERATURE REVIEW
2.1. Drug Profile
NELARABINE:-
Chemical structure            :
                                          
                       Fig no. 2.1. Structure of Nelarabine
 IUPAC name                 :           (2R,3S,4S,5R)-2-(-2-amino-6-methoxy-
9H-purin-9yl)-5-(hydroxymethyl)oxolane-3,4-diol
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 Molecular Formula        :         C11H15N5O5
 Molecular Weight          :        297.267
 CAS number                  :         121032-29-9
 General properties:-
Colour                             :          White powder
State                                :         Crystalline powder
Solubility                        :          Slightly soluble to soluble in water, 
soluble in   
                                                    methanol.                                                
Melting point                 :           209-2170C 
 Dosage form                  :            Injection
 Stability                         :            Nelarabine Injection is stable in 
polyvinyl- chloride (PVC) infusion bags and glass containers for 8 hours
up to 30° C
 Category                        :           Antineoplastic agent .Used in treatment 
of T-cell acute lymphoblastic leukemia.
 Brand names                :            Arranon (Glaxosmithkline), Atriance
 Official                          :             Not official in any Pharmacopoeias
 Mechanism  of  action     :    Nelarabine  is  a  pro-drug  of  the
deoxyguanosine  analogue 9-β-D-arabinofuranosylguanine  (ara-G).
Nelarabine is demethylated by adenosine deaminase (ADA) to ara-G,
mono-phosphorylated  by  deoxyguanosine kinase  and  deoxycytidine
kinase,  and subsequently  converted to the active  5’-triphosphate,  ara-
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GTP.  Accumulation  of  ara-GTP  in  leukemic  blasts  allows  for
incorporation into deoxyribonucleic acid (DNA), leading to inhibition of
DNA synthesis and cell death. Other mechanisms may contribute to the
cytotoxic and systemic toxicity of nelarabine.
 Side effects   : Nelarabine may cause serious side effects of the central
nervous system.[18]
Formulation :
Table no. 2.1.Various brands of the formulation 
Formulation
Nelarabine
(mg/mL) Manufacturer
Arranon [19]    5 GlaxoSmithKline
Atriance
              5 GlaxoSmithKline
                              2.2 REVIEW OF LITERATURE
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Huang Qiaoqiao et al.,(2012)  established a nonaqueous titration method for
the  determination  of  Nelarabine  using  0.1  mol/L  perchloric  acid  as  titrant.
Effect  of  different  solvents  and  indicators  on  the  titration  endpoint  was
compared  in  this  paper.  Using  acetic  acid  as  solvent  and  determining  the
endpoint  potentiometrically  5  times,  the  average  content  of  Nelarabine  was
found to be 99.8%(RSD=0.22%). The method is simple and precise,and can be
used to determine the content of Nelarabine in APIs.[20]
Yoshiyuki Minamide1, Minamide, et al.,(2012) developed a  highly sensitive
liquid  chromatography  tandem mass  spectrometry  (LC-MS/MS)  method  for
quantitation of arabinofuranosyl guanosine 5’-triphosphate (ara-GTP) in human
peripheral blood mononuclear cells (PBMC) and  validated using a standard
addition method with the human Tlymphoblastoid cell line as an alternative
blank matrix. Ara-GTP was extracted with methanol/250 mmol/L ammonium
carbonate solution (7/3, v/v) from the cells at a density of 106 cells per 0.5 mL.
Extracts were subjected to LC-MS/ MS using a TurboIon spray interface and
selected reaction monitoring  with the transitions  of  m/z  524 to  m/z  152 for
quantitation. Endogenous guanosine triphosphate in the extract was used as an
internal standard. Separation of the analytes was achieved on a porous graphitic
carbon column (100 mm length × 2.1 mm i.d., 5 µm particle size) by isocratic
elution  with  250  mmol/L  ammonium  carbonate  buffer  (pH
9.5)/water/acetonitrile (40/51.5/8.5, v/v/v) at a flow rate of 0.2 mL/min. The
method  was  validated  in  the  range  of  2–250  pg/mL.  The  pharmacokinetic
profile  of  ara-GTP  in  PBMC  in  a  Phase  I  clinical  study  of  nelarabine  in
relapsed  or  refractory  T-ALL/T-LBL  patients  was  successfully  determined
using this method.[21]
Jeanette Kaiser and Krämer et al.,(2011) developed a   stability-indicating
reversed-phase  high  performance  liquid  chromatography  with  ultraviolet
detection  for  determining  Physico-chemical  stability  of  nelarabine  infusion
solution  in ethylene vinyl  acetate infusion bags.  The column used was the
Spherisorb ODS-2 C18, end-capped, 80 Å x 4.6 mm, particle size 3 µm, mobile
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phase  consisted  of  80% 0.01  M potassium  dihydrogen  phosphate  (pH 6.8)
solution and 20% methanol.The flow rate was set at 1.0 mL/minute, with an
injection volume of 10 µL. The detection wavelength was set at 265 nm. The
stability  tests  revealed  that  nelarabine  infusion  solutions  are  physico-
chemically  stable  for  a  minimum  of  four  weeks.  Nelarabine  concentrations
remained at a level of > 95% of the initial concentration independent of the
storage conditions.[22]
N.Y.Sreedhar,  C.Nageswara  Reddy  (2011)  developed  a  robust,  highly
reliable and reproducible adsorptive stripping voltammetric procedure for the
determination of nelarabine in pharmaceutical formulations and urine samples.
The  analytical  procedure  was  based  on  the  reduction  of  the  >C=N-  of  the
pyrozole  ring  of  the  drug  molecule  at  the  hanging  mercury  drop
electrode(HMDE)  surface  in  Universal  buffer  of  pH  6.0.  The  optimal
experimental  parameters  for  the  drug  assay  were,  accumulation  potential
-0.78V (vs.  Ag/AgCl),  accumulation  time  60sec,pulse  amplitude  25mV and
scan rate 40mV s-1  in universal buffer (pH.6.0).The linear concentration range
of application was 1.0×10-2 to 1.0×10-7 M of nelarabine, with a relative standard
deviation  of  1.3%  and  a  detection  limit  of  1.0×10-7 M.  The  method  was
successfully applied  to  the  determination  of  nelarabine  in  human urine  and
pharmaceutical formulations.[23]
                          
Takahero  Yamauchi,  Rie  Nish et  al.,(2009) developed  a  new,  sensitive
isocratic  elution HPLC   method  for  determining  low production  of  9-ß-D-
arabinosylguanine triphosphate, an active metabolite of nelarabine  in adult T-
cell leukemia cells. The determination of ara-GTP production in cancer cells is
informative for optimizing nelarabine administration. The developed method
showed   λmax at  254nm,  and  samples  were  eluted  isocratically  by  using
phosphate  buffer  (80% 0.06M Disodium  hydrogen  phosphate  pH and  20%
ACN) at a constant flow rate  0.7ml/min and injection volume 10 µ L . Ara-
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GTP was clearly separated from other nucleotides by using an anion-exchange
column DEAE 2 SW(250×4.6mm) and it was quantitated by its peak area. The
standard curve was linear with % CV less than 10 and a sensitive detection
limit  (10 pmol).  This  study was the  first  to evaluate  the  potential  of  ara-G
against ATL cells.[24]
Berg SL, Brueckner C, Nuchtern JG, Dauser R, McGuffey L, Blaney SM
(2007) studied Plasma and cerebrospinal fluid pharmacokinetics of nelarabine
in  nonhuman  primates  using  LC-MS  method. Nelarabine  (35  mg/kg,
approximately  700 mg/m2)  was administered  over  1  h  through  a  surgically
implanted  central  venous  catheter  to  four  nonhuman  primates.  Blood  (four
animals)  and  ventricular  CSF  (three  animals)  samples  were  obtained  at
intervals for 24 h for determination of nelarabine concentrations, which were
measured  by  HPLC-mass  spectrometry. The  nelarabine  plasma  AUC
(median+/-s.d.)  was 2,820+/-1,140 microM min and the ara-G plasma AUC
was  20,000+/-8,100  microM  min.  The  terminal  half-life  of  nelarabine  in
plasma was 25+/-5.2 min and clearance was 42+/-61 ml/min/kg. The excellent
CSF  penetration  of  nelarabine  and  ara-G  supports  further  study  of  the
contribution of nelarabine to the prevention and treatment of CNS leukemia.[25]
Carlos O. Rodriguez Jr.,  and William Plunkett et  al.,(2000) developed a
gradient  anion-exchange  high-performance  liquid  chromatographic  assay for
the simultaneous determination and quantitation of the cytotoxic triphosphates
of  arabinosylguanine  (ara-GTP)  and fludarabine  (F-ara-ATP).  To  assess  the
clinical  utility,  perchloric  acid  extracts  of  circulating  human  leukemia  cells
isolated from patients treated with fludarabine and nelarabine were analyzed.
Samples were eluted gradiently using  60% 0.005  M NH4 H2 PO4 (pH 2.8)
and 40% 0.75 M NH4 H2 PO 4  (pH 3.6) at a constant flow-rate of 1.5 ml/min,
in 10-SAX Partisil anion-exchange column (4.6×250 mm, Whatman, Clifton,
NJ,  USA) and  UV  absorption  at  256  nm .  The  range  of  quantitation  was
0.0125–10 nmol for the ara- and native NTPs in cellular extracts. This assay
should be helpful in establishing the mechanistic rationales for drug scheduling
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and  combinations  of  nelarabine  and fludarabine,  and  for  correlating  the
therapeutic efficacy and levels of the cytotoxic triphosphates in target cells.[26]
2.3. RESEARCH ENVISAGED
From the literature survey it is clear that only one RP-HPLC method have been
reported so far for Nelarabine in commercially available formulation. Very few
methods  have  been  reported  in  determination  of arabinosyl  guanine
triphosphate, active form of nelarabine present in biological fluids. Hence an
attempt  has  made  to  develop  a  RP-HPLC  method  for  the  estimation  of
Nelarabine in bulk and pharmaceutical dosage form.
Present  work  is  aimed  at  to  develop  a  new,  simple,  fast,  rapid,  accurate,
efficient and reproducible RP-HPLC method for the analysis of Nelarabine and
to validate the developed method according to ICH (Q2b)  guidelines.  
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3.1. PLAN OF WORK
The experimental work has been planned as follows
           STEP 1-
• Study of physico-chemical properties of drug (pH, pka, solubility, and
molecular weight)
• Preparation of drug standard and sample solution
• Selection of stationary phase
• Selection of mobile phase
• Preparation of solutions
• Developing  simple,  rapid  and  specific  RP-HPLC  method  for  the
quantitative estimation of Nelarabine in the dosage form.
• Optimizing the chromatographic conditions
STEP 2-To validate the newly developed method in accordance with the
analytical validation parameters mentioned as ICH guidelines(Q2B)
 Selectivity/specificity 
 Linearity and range 
 Accuracy 
 Precision (repeatability and reproducibility) 
 Limit of detection (LOD)
 Limit of quantification (LOQ) 
 Robustness
 Forced degradation studies
3.2 Materials and Methods
3.2.1 Chemicals and standards used
Table.No.3.1. List of Chemicals and standards used
S.NO Chemicals/reagents Grade Manufacturer
1 Methanol GR Merck
2 Acetonitrile GR Merck
3 Purified water Milli-Q NA
4 Trifluoroacetic acid GR Merck
3.2.2 Equipment used during assay development
                      Table.No.3.2. List of equipment used
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S. No. Name Manufacturer
1. HPLC(empower-2software) Aliance waters(2489)
2. HPLC detector UV/Visible detector
3. pH Meter Lab india
4. UV Spectrophotometer SHIMADZU
5. Micro Balance Mettle Toledo
6. Water Purifier Millipore
3.3. METHODOLOGY
3.3.1Assay method development:
The project work entitled as ‘Development and validation of stability indicating RP-
HPLC for  estimation of Nelarabine  in bulk and pharmaceutical  dosage  form’  was
carried out at Natco Pharma Limited, Kothur, Hyderabad.
A new RP-HPLC method was developed for the determination of nelarabine in i.v
infusion  .  The  HPLC method was  then  validated  to  indicate  that  the  analytical
procedure  used  is  suitable  for  intended  use  by  using  various  parameters  like
specificity, linearity, precision, accuracy, system suitability.
3.3.1.1 Selection of initial conditions for Method Development:    
Determination of absorption maxima by UV/Visible Spectroscopy:
Accurately weighed and transferred about 100mg of nelarabine working standard into
a 100ml volumetric flask, then added to it about 60 ml of methanol and sonicated for
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10 minutes to dissolve and diluted up to mark with methanol and mix well. Further
dilute 10ml ofthe above solution to 100ml with methanol and mix well. Finally dilute
10ml of above solution to 100ml with methanol. Final concentration of Nelarabine is
about 10 ppm. 
The  solution  was  scanned  over  a  range  of  200-400nm  and  a  UV  spectrum  was
recorded. The best possible wavelength was chosen as 266nm.
3.4.METHOD DEVELOPMENT OF NELARABINE INFUSION BYRP-HPLC
The method was developed mainly basing on pka concept of drug and mobile phase
composition, flow rate,λmax, different columns and column temperature.Nelarabine has
two pka values that are 12.45 and 3.45. Generally pH of buffer solution should be
 1 of pka value of drug. In this method pKavalue 3.45was selected because
in  HPLC,  solution  may  damage  column  with  pH  more  than10.  So  pka12.45  of
Nelarabinewas eliminated. Then trials were performed by adjusting pH of buffer 1
ofpKa value 3.45 and also by changing mobile phase composition. Finally good peak
was obtained at pH 2.44 of buffer and retention time was also less compared to other
trials. So the method was optimized at these conditions.
Further validation study was  performed as per ICH guidelines.
Trial- 1
Chromatographic conditions: 
Mobile phase    : 0.1% Trifluoroacetic acid and acetonitrile in the ratio 60:40v/v
Column             :   Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate           : 1.0 ml/min 
Detector wavelength  : 266 nm 
Column temperature  : 300C
Injection volume        : 10 µL 
Run time                    : 8 min 
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Retention time           : 5.97 min
Inference:An extra peak and peak tailing appeared
Trial-2
Chromatographic conditions: 
Mobile phase   : 0.1% Trifluoroacetic acid and acetonitrile in the ratio 60:40v/v
Column             : Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate           : 1.3 ml/min 
Detector wavelength   : 266 nm 
Column temperature   : 300C
Injection volume         : 10 µL 
Run time                      : 8 min 
Retention time                 : 5.77 min
Inference:Peak tailing appeared with improper baseline.
Trial-3
Chromatographic conditions: 
Mobile phase     :0.1% Trifluoroacetic acid and acetonitrile in the ratio 80:20v/v
Column              : Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate            : 1.3 ml/min 
Detector wavelength     : 266 nm 
Column temperature      : 300C
Injection volume            : 10 µL 
Run time                         : 8 min 
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Retention time                : 5.42 min
Inference:peak tailing is obtained
Trial-4
Chromatographic conditions: 
Mobile phase   :0.01% Trifluoroacetic acid and acetonitrile in the ratio 60:40v/v
Column            : Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate          : 1.0 ml/min 
Detector wavelength  : 266 nm 
Column temperature   : 300C
Injection volume         : 10 µL 
Run time                      : 8 min 
Retention time             : 5.775 min
Inference: Tailing factor is more than 2 and baseline disturbance appeared.
Trial-5
Chromatographic conditions: 
Mobile phase   :0.01% Trifluoroacetic acid and acetonitrile in the ratio 80:20v/v
Column            : Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate          : 1.0 ml/min 
Detector wavelength        : 266 nm 
Column temperature         : 300C
Injection volume               : 10 µL 
Run time                           : 8 min 
Retention time                  : 4.51min
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Inference: Baseline is not proper
Trial-6
Optimized Chromatographic conditions: 
Mobile phase  : 0.01% Trifluoroacetic acid and acetonitrile in the ratio 85:15v/v
Column           : Cosmicsil Adze C18 column (150×4.6mm,5µm)
Flow rate         : 1.0 ml/min 
Detector wavelength    : 266 nm 
Column temperature     : 300
Injection volume           : 10 µL 
Run time                        : 8 min 
Retention time               : 3.83 min
Inference: Sharp peak was obtained at 3.83minutes.
3.4.1.Preparation of solutions:
Buffer Preparation: 
100µL of Trifluoroacetic acid was transferred in to 1000mL of purified water 
and mixed well.Finally the solution was filtered through 0.45µm membrane 
filter and degassed.
Mobile phase
The buffer and acetonitrile were mixed in the ratio of  85:15 v/v respectively 
and degassed.
Diluent
Purified water was used as diluent.
3.4.2.Preparative Steps for Assay method development:
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Standard Preparation:
Accurately  20.0mg  of  Nelarabine  working  Standard  was  weighed  and
transferred into a 100 ml clean ,dry volumetric flask, and 60 ml of diluent
was added and sonicated to dissolve.  The solution was cooled to room
temperature and diluted to volume with diluent. Then 1.0 ml of the above
solution  was  transferred  into  10  ml  volumetric  flask  and  diluted  with
mobile phase.
Sample preparation:  
2mL of sample was transferred  into 50 ml of clean, dry volumetric flask.
About  20  ml  of  diluents  was  added  and  sonicated  for  15  min  with
occasional  shaking.  The solution  was  cooled  to  room temperature  and
diluted  to  20ml  with  diluent.Then  1.0  ml  of  above  solution  was
transferred into 10 ml volumetric flask and diluted with mobile phase.
Where,                             
      TA = peak area response due to Nelarabine from sample
      SA = peak area response due to Nelarabine from standard
      SW = Weight of Nelarabine working standard takenin mg
      TW = weight of sample taken in mg
      P     = purity of Nelarabine working standard taken on as is basis
3.4.3.SYSTEM SUITABILITY:
Chromatograph the standard preparation (Six replicate injections), measure the
peak area responses for the analyte  peak and evaluate the system suitability
parameters as directed.
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Standard Preparation:
Weigh and transfer accurately 100 mg of Nelarabine working standard into a
100 ml clean, dry volumetric flask and add about 60 ml of diluent  and sonicate
to dissolve. Cool the solution to room temperature and dilute to volume with
solvent mixture. Then transfer 10.0 ml above solution into 100 ml volumetric
flask and dilute with mobile phase.A Standard solution was prepared by using
Nelarabine working standard as per test method and was injected six timesinto
the HPLC system.
Acceptance criteria:
 %RSD for replicate injections of peak area response for Nelarabine
peak from the standard preparation should be not more than 2.0.
 The Tailing factor for Nelarabine peak should be not more than 2.0.
 The number of Theoretical plates for Nelarabine peak should be not
less than 2000
3.5. ANALYTICAL METHODVALIDATION
Validation  was  done  for  the  developed  method  as  per  ICH  Guidelines
(Q2B).The method validation parameters for assay of Nelarabine include        
 Specificity
 Accuracy
 Linearity and Range
 Precision
Repeatability
Intermediate precision (ruggedness)
 Detection Limit
 Quantitation Limit
 Robustness
3.5.1. SPECIFICITY: 
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Specificity  of  the  developed  method  was  determined  by  injecting  blank,3
replicates  of  working  standard  solution  and  3  replicates  of  working  sample
solution containing 20µg/ml of Nelarabine.
3.5.2. LINEARITY AND RANGE:
Preparation of stock solution
Weigh and transfer accurately 100mg Nelarabine working standard into a 100
ml clean,dry volumetric flask  and add about 60 ml of diluentand sonicated to
dissolve.  Cool  the  solution  to  room temperature  and  dilute  to  volume  with
diluent.  Then transfer  10.0  ml  of  theabove  solution into  100 ml  volumetric
flask and dilute with mobile phase.
Preparation of Level – I (20 µg/mL) 
2.0ml of stock solution was taken in to 10ml of volumetric flask and dilute up
to the mark with mobile phase. 
Preparation of Level – II (40 µg/mL) 
4.0ml of stock solution was taken in to 10ml of volumetric flask and dilute up
to the mark with mobile phase.
Preparation of Level – III (60 µg/mL) 
6.0ml of stock solution was taken in to 10ml of volumetric flask and dilute up
to the mark with mobile phase. 
Preparation of Level – IV (80 µg/mL)
8.0ml of stock solution was taken in to 10ml of volumetric flask and dilute up
to the mark with mobile phase.
Preparation of Level – V (100 µg/mL)
10ml of stock solution was taken in to 10ml of volumetric flask 
Procedure
Each level was injected into the chromatographic system and peak area was
measured.Plot  a  graph  of  peak  area  versus  concentration  (on  X-axis
concentration  and  on  Y-axis  Peak  area)  and the  correlation  coefficient  was
calculated. 
     Acceptance Criteria 
     Correlation coefficient should not be less than 0.999
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    RANGE 
Based on precision, linearity and accuracy data it can be concluded that the 
assay method is precise, linear and accurate in the range of 50-150% of 
Nelarabine.
3.5.3 ACCURACY
Preparation of stock solution: 
 Accurately weigh and transfer 10 mg of Nelarabine working standard into a 10
mL                                                                                                    volumetric
flask add about 7 mL of  diluent and sonicate to dissolve it  completely and
make volume    up to the mark with the same solvent. (Stock solution)
Preparation of 60 µg/ml solution:
Further pipette 0.6 ml of the above stock solution into a 10ml volumetric flask 
and dilute upto the mark with diluent. Mix well and filter through 0.45µm 
filter.
Preparation of Nelarabine sample solution:
For preparation of 50% solution (With respect to target Assay 
concentration):
1 mL of Nelarabine sample was taken  into a 10 mL volumetric flask and about
7 mL of diluent was added.The resulted solution was sonicated and the volume
was made to the mark with the same solvent. (Stock solution)
Pipette 0.6 ml of the above stock solution into a 10ml volumetric flask and
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.
For preparation of 100% solution (With respect to target Assay 
concentration):
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1 mL of Nelarabine sample was taken  into a 10 mL volumetric flask and about
7 mL of diluent was added.The resulted solution was sonicated and the volume
was made to the mark with the same solvent. (Stock solution)
Pipette 1.2 ml of the above stock solution into a 10ml volumetric flask and
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.
For  preparation  of  150%  solution  (With  respect  to  target  Assay
concentration):
1 mL of Nelarabine sample was taken  into a 10 mL volumetric flask and about
7 mL of diluent was added.The resulted solution was sonicated and the volume
was made to the mark with the same solvent. (Stock solution)
Pipette 1.8 ml of the above stock solution into a 10ml volumetric flask and 
dilute up to the mark with diluent. Mix well and filter through 0.45µm filter.
Procedure
The standard solution was spiked with sample of accuracy level 50% ,100%,150%
and  injected  into  chromatographic  system. Calculate  the  amount  found  and
amount  added  for  Nelarabine  and  the  individual  %  recovery  and  mean  %
recovery values were calculated.
Acceptance Criteria
The % Recovery for each level should be between 98.0 to 102.0%.
3.5.4 .PRECISION
Repeatability
Preparation of stock solution
Weigh and transfer accurately 100 mg of Nelarabine working Standard into a
100  ml  clean,  dry  volumetric  flask  and  add  about  60  ml  of  diluent  and
sonicated  to  dissolve.  Cool  the  solution  to  room temperature  and  dilute  to
volume with solvent mixture. 
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Sample Preparation:
Then transfer 2.0 ml above solution into 100 ml volumetric flask and dilute 
with mobile phase.
Procedure:
The standard solution was injected for six times and measured the area for all six
injections in HPLC. The %RSD for the area of six replicate injections was found
to be within the specified limits.
Acceptance Criteria
The % RSD for the area of six standard injections results should not be more 
than 2
Intermediate Precision/Ruggedness 
To evaluate the intermediate precision (also known as Ruggedness) of the 
method,  Precision was performed on different day by using different make 
column of same dimensions.  
Preparation of stock solution
Weigh and transfer accurately 100 mg of Nelarabine working Standard into a 
100 ml clean. dry volumetric flask and add about 60 ml of diluent  sonicated to 
dissolve. Cool the solution to room temperature and dilute to volume with 
solvent mixture. 
Sample Preparation:
Then transfer 2.0 ml above solution into 100 ml volumetric flask and dilute 
with mobile phase
Procedure
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The standard solution was injected for six times and measured the area for all six
injections in HPLC. The %RSD for the area of six replicate injections was found
to be within the specified limits.
        Acceptance Criteria
      The % RSD for the area of six  sample injections results should not be more 
than 2%.
3.5.5 LIMIT OF DETECTION AND QUANTIFICATION 
Detection Limit
The Detection Limit of an individual analytical procedure is the lowest amount 
of analyte in a sample which can be detected but not necessarily qualtitated as 
an exact value.
Preparation of 60µg/mL solution:  
Accurately weighed and transferred 10mg of Nelarabine working standard into
10mL volumetric flask.To that 7mL of diluent was added and sonicated. The
volume was made up to the mark with the same diluent. (Stock solution).
Further 0.6mL of the above stock solution was pipetted into 10mL volumetric
flask and diluted to the mark with diluent. The solution was mixed and filtered
through 0.45µm filter.
Preparation of 1.0% solution At Specification level (0.029µg/ml solution):
1 mL of 10µg/mL solution was pipetted into 10mL volumetric flask and diluted
up to the mark with diluent. Further 0.9 mL of above solution was pipette into
10mL volumetric flask and diluted up to the mark with diluent.
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Further 0.3mL of above diluted solution was pipetted into 10mL volumetric
flask and diluted up to the mark with diluent.
Quantitation Limit
The Quantitation limit of an analytical procedure is the lowest amount of 
analyte in a sample which can be quantitatively determined with suitable 
precision and accuracy.
Preparation of 60µg/mL solution:  
Accurately weighed and transferred 10mg of Nelarabine working standard into
10mL Volumetric flask.To that 7mL of diluent was added and sonicated. The
volume was made up to the mark with the same diluent. (Stock solution)
Further 0.6mL of the above stock solution was pipetted into 10mL volumetric
flask and diluted to the mark with diluent. The solution was mixed and filtered
through 0.45µm filter.
Preparation of 0.9% solution At Specification level (0.095µg/ml solution):
1.0mL of above solution was pipetted into 10mL volumetric flask and diluted
up to  the  mark  with  diluent.1.0mL of  the  solution was pipetted  into  10mL
volumetric flask and diluted up to the mark with diluent.
Further 0.9 mL of above diluted solution was pipetted into 10mL volumetric
flask and diluted up to the mark with diluent.
3.5.6.ROBUSTNESS:
The  Robustness  of  analytical  procedure  is  a  measure  of  its  capacity  to
remain  unaffected  by  small  but  deliberate  variations  in  procedural
parameters  listed  in  theprocedure  documentation  and  indication  of  its
suitability  during  normal  usage.Examples  of  typical  variations  in  assay
method validation by HPLC are:
 Mobile phase flow rate
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 Influence of variation in mobile phase composition etc.
± 0.1 ml/min flow rate:
Standard solution of 20µg/mL of Nelarabine was prepared and analysed at 0.9
mL/min and 1.1mL/min i.e. at ± 0.1 unit of optimised flow rate (1.0 mL/min).
± 5% in  mobile phase composition:
Standard  solution of  20µg/mL of  Nelarabine  was prepared by changing the
mobile phase ratio by ± 5% and analysed 
       Acceptance Criteria
       The % RSD for the area of six  sample injections results should not be more 
than 2%
3.6. Forced degradation studies
Forced  degradation  studies  are  typically  performed  to  assess  physical  and
chemical stability of the drug product. These studies are also used to determine
the  degradation pathways of drug substances and drug products, the intrinsic
stability of the drug substance molecule in solution and solid state. 
Prepation of sample stock solution (100 µg/mL):
2  mL  of  sample  was  taken  from  the  Nelarabine  injection
solution(250mg/50mL)  in  to  a  100  mL volumetric  flask  and  diluted  to  the
volume using the diluent.
3.6.1 Acid degradation:
Acid degradation studies were carried out by adding 10 mL 1.5 N HCl to 5 mL
of above solution and by refluxing the solution at 600C for 2 hours. Then 10mL
of 1N NaOH was added and volume was made up to 50 mL with diluent.Then
the samples were injected through proposed HPLC method.
3.6.2 Alkali degradation:
Base degradation studies were carried out by adding 10 mL of 1.5 N NaOH to
5 mL Nelarabine sample solution and by refluxing the solution at 600C for 2
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hours. Then 10mL of 1N HCl was added and volume was made up to 50 mL
with diluent.Then the samples were injected through proposed HPLC method. 
3.6.3 Oxidative degradation:
Peroxide degradation studies were carried out by adding 1 mL of 30% H2O2 to
5mL of Nelarabine sample solution and by refluxing the solution at 400C for 2
hours.Then volume was made up to 50mL with diluent. Then the samples were
injected through proposed HPLC method. 
3.6.4 Thermal degradation:
Thermal  degradation  studies  were  carried  out  for  5mL  Nelarabine  sample
solution in 50 mL volumetric flask which was diluted to mark using diluent.
Resulting solution was subjected to 800C for 2 hours. Then the samples were
injected through proposed HPLC method.
3.6.5 Photolytic degradation
Photolytic degradation studies were carried out by exposing 5mL Nelarabine
sample solution to UV lamp in UV cabinate at 254nm for 2 hours. Finally the
volume was made upto mark in 50mL volumetric flask using diluent. Then the
samples were injected through proposed HPLC method.
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                                  4. RESULTS AND DISCUSSION
The present study was aimed to develop a new method for the estimation of
Nelarabine  by  stability  indicating  RP-HPLC  and  to  validate  the  developed
method.  The  literature  survey  revealed  that  only  one  HPLC  method  was
reported for Nelarabine in pharmaceutical dosage form. Hence an attempt has
been made to develop a RP-HPLC method for the determination of Nelarabine
in bulk and pharmaceutical dosage form.
4.1. ANALYTICAL METHOD DEVELOPMENT
4.1.1 Selection of wavelength:
The  detection  wavelength  was  determined  by  dissolving  Nelarabine  in
Methanol to get a concentration of 10 µg/ml. The solution was scanned in U.V
region from 200-400nm. The absorbance maximum was found to be 266nm.
The spectrum was shown in fig.No.4.1.
                                          
                           Fig.No.4.1. UV spectra of Nelarabine 
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4.1.2  Method  Development  and  Optimization  of  Chromatographic
Parameters:
The chromatographic method was developed for the estimation of Nelarabine
by optimizing several parameters like flow rate, mobile phase, and run time and
elution technique.
4.1.3. Method development trials:
 Trial 1:
                                    Fig.No.4.2. Chromatogram of Trial 1
Inference: An extra peak and peak tailing appeared.
Trail 2:
                            Fig.No.4.3. Chromatogram of Trial 2
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Inference: Peak tailing appeared with improper baseline.
Trail 3: 
                               Fig.No.4.4. Chromatogram of Trial 3
Inference: peak tailing is obtained.
Trail 4:
                          Fig.No.4.5. Chromatogram of Trial 4
Inference: Tailing factor is more than 2 and baseline disturbance appeared.
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Trail 5:
                                            Fig.No.4.6. Chromatogram of Trial 5
Inference: Baseline is not proper.
Trail 6: Optimized Method
                                           Fig.No.4.7. Chromatogram of Trial 6
Discussion: sharp  peak  was  eluted  at  3.83  min.  Plate  counts,  Tailing  factor  and
Resolution were within acceptable limits.
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4.1.4. Optimized chromatographic conditions
The optimized chromatographic  conditions  for the  method development  and
validation of Nelarabine are as follows
                      Table no.4.1. Optimized Method conditions
S.No Parameter Condition
1 Column Cosmicsil Adze C18
column(150×4.6mm,5µm)
2 Mobile Phase 85:15 v/v 0.01% Trifloroacetic acid 
(pH 3.0) and Acetonitrile
3 Column Temperature 300C
4 Wavelength 266nm
5 Flow rate 1.0 ml/min
6 Auto sampler temperature Ambient
7 Injection volume 10µL
8 Run time 8 minutes
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4.2.  Estimation  of  Nelarabine  in  formulation  by  developed  RP-HPLC
method:
A.Assay:
                         Fig.No.4.8. Chromatogram of Blank
                             Fig.No.4.9. Chromatogram of Standard
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                                           Fig.no.4.10. Chromatogram of Sample
           
 Peak results for test preparation (Assay)
                                    Table 4.2. Product Label
Product name Arranon (Nelarabine) injection
Active ingredient Nelarabine
Label claim mg/mL 250mg/50mL in each vial
% purity 99.9
                             Table no.4.3. Peak responses
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Name Nelarabine
Peak Area of sample 2308368
Peak Area of standard 2309481
Weight of working standard
in mg
20.0
Weight of sample in mg 10.0
% assay 99.4
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Assay calculation-: 
      TA = peak area response due to Nelarabine from sample
      SA = peak area response due to Nelarabine from standard
      SW = Weight of Nelarabine working standard taken in mg
      TW = weight of sample taken in mg
      P      = purity of Nelarabine working standard taken on as is basis
B. System Suitability Results:
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Fig.No.4.11. Chromatograms for system suitability
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                     Table.No.4.4. system suitability data of Nelarabine
S.No Rt (min)       Area USP
Tailing
Plate 
count
Height
1 3.856 2309481 1.3 3905.1 243220
2 3.834 2324212 1.3 3862.4 242034
3 3.850 2321743 1.3 3903.0 242111
4 3.839 2309743 1.3 3804.6 240877
5 3.835 2308368 1.3 3850.7 240742
6 3.840 2306722 1.3 3825.0 240983
Mean 2313375 1.3
SD 7553.667
%RSD
    0.326
           Discussion: All the system suitability parameters were within limits.
4.3.  ANALYTICAL  METHOD  VALIDATION  OF  RP-HPLC
METHOD
Validation of an analytical  method is  the process  to establish  by laboratory
studies  that  the  performance  characteristic  of  the  method  meets  the
requirements  for  the  intended  analytical  application.  Performance
characteristics were expressed in terms of analytical parameters.
4.3.1. SPECIFICITY
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The system suitability  for  specificity  was carried  out  to  determine  whether
there is any interference at the  retention time of analytical peak.
                        Fig.No.4.12. Chromatogram of Blank
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                         Fig.No.4.13. Chromatogram of Standard
                           Fig.No.4.14. Chromatogram of sample
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Discussion: No interference was observed at the retention time of the analyte.
4.3.2. LINEARITY AND RANGE
The linearity of a method is its ability to obtain test results that are directly
proportional  to  the  sample  concentration  over  a  given  range.  Linearity  was
established by least squares regression analysis of the calibration curve. The
linearity study was performed for the concentration of 20µg/mL to 100µg/mL
level.  Each level  was injected into chromatographic  system.  The calibration
curve was plotted for Peak areas against respective concentrations and linear
regression analysis was performed on the resultant curves. The chromatograms
were shown in fig.No.4.15-4.19 and table no.4.5.
                                Fig.No.4.15. HPLC chromatogram of linearity 20µg/mL
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                              Fig.No.4.16. HPLC chromatogram of linearity 40µg/mL
                                   Fig.No.4.17. HPLC chromatogram of linearity 60µg/mL
                                 Fig.No.4.18. HPLC chromatogram of linearity 80µg/mL
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                                    Fig.No.4.19. HPLC chromatogram of linearity
100µg/mL
                                  Table.No.4.5. Linearity data of Nelarabine
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S.No Linearity Level Concentration Area
1 I 20 µg/mL 2242651
2 II 40  µg/mL 4236227
3 III 60  µg/mL 6251237
4 IV 80  µg/mL 8360119
5 V 100  µg/mL 10351126
Correlation Coefficient 0.9995
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                                         Fig.No.4.20. Linearity plot of Nelarabine
Discussion
Nelarabine was found to be linear over the range of 20-100µg/mL. Correlation
coefficient value for calibration plot of Nelarabine was found to be 0.999. 
4.3.3. PRECISION
Precision of method was demonstrated by
a) Repeatability
b) Intermediate precision
c) Reproducibility
a) Repeatability
The Repeatability studies were studied by six replicate measurements and
the % RSD of peak area was calculated. 
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                      Fig.No.4.21. HPLC chromatograms for Repeatability
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Table.No.4.6. Repeatability data of Nelarabine
  
b) Intermediate precision/Ruggedness
The intermediate precision was carried out on same HPLC system, using same
column on another day. The Intermediate precision studies were studied by six
replicate  measurements  and  the  %  RSD  of  peak  area  was  calculated.
The chromatograms  were  shown in  Fig.No.4.22  and results  are  tabulated  in
Table.No.4.7.
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S.No Area
1 2332801
2 2328717
3 2385913
4 2335516
5 2344025
6 2345394
Mean 2345394.3
         SD 20870.7661
%RSD 0.889
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                Fig.No.4.22. HPLC chromatograms for Intermediate precision
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Table.No.4.7. Intermediate precision data of Nelarabine
S.No Area
1 2471937
2 2413336
3 2423902
4 2437684
5 2445010
6 2438374
Mean 2438373.8
 SD 20036.605
%RSD 0.821
Discussion:  The %RSD values calculated for repeatability  and intermediate
precision were found to be within limits (%RSD < 2).
4.3.4. ACCURACY 
The accuracy of the method shall be demonstrated through determination on
samples in three concentrations from 50%, 100% and 150% three replicates
each of the theoretical concentrations employed as per the usual procedure and
the chromatograms were recorded and % recovery was calculated. 
                             Table.No.4.8. Accuracy results of Nelarabine
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%concentration
(at specification
level)
Area Average
area
Amount
found(µg/mL)
Amount
added(µg/mL)
%Recovery Mean
recovery
2127297
50 2121167 2126881 30.10 29.94 100.54
2132178
4236227
100 4239885 4236598 59.97 59.88 100.15 99.81
4233682
6251237
150 6265225 6264031 88.67 89.82 98.72
6275631
   Fig.No.4.23. HPLC chromatogram for accuracy 50% ( prep-1)
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                      Fig.No.4.24. HPLC chromatogram for accuracy 50% ( prep-2)
        Fig.No.4.25. HPLC chromatogram for accuracy 50% ( prep-3)
                     Fig.No.4.26. HPLC chromatogram for accuracy 100% (prep-1)
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                 Fig.No.4.27. HPLC chromatogram for accuracy 100% (prep2)
        Fig.No.4.28. HPLC chromatogram for accuracy 100% (prep3)
      Fig.No.4.29. HPLC chromatogram for accuracy 150% (prep-1)
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   Fig.No.4.30. HPLC chromatogram for accuracy 150% (prep-2)
      Fig.No.4.31. HPLC chromatogram for accuracy 150% (prep-3)
Discussion:  The percentage recovery of Nelarabine was found to be 100.4%,
100.12% and 98.72% for accuracy 50%, 100% and 150% samples respectively.
The percentage recovery was within   98% -102%. The %RSD of the samples
was found to be less than 2.
4.3.5. Limit of detection (LOD)
LOD is the lowest amount of analyte in a sample that can be detected but not
necessarily  quantitated  under  the  stated  experimental  conditions.  LOD  was
calculated  by  using  standard  deviation  and  slope  values  obtained  from
calibration curve. The chromatogram was shown in fig.4.32. 
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Fig.No.4.32. LOD chromatogram
Table.No.4.6.LOD results of  Nelarabine
                            
Calculation of S/N Ratio:
 Average Baseline Noise obtained from Blank = 48 µV
 Signal Obtained from LOD solution = 148 µV 
S/N = 148/48 = 3.08
Discussion:  The S/N ratio was found to be within limits and it was calculated
as 3.08:1. 
4.3.6 Limit of quantification (LOQ)
LOQ is the lowest amount of analyte in a sample, which can be quantitatively
determined with  acceptable accuracy and precision.  LOQ was calculated by
using standard deviation and slope values obtained from calibration curve. The
chromatogram was shown in fig.No.4.33.
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Fig.No.4.33.LOQ chromatogram
    Table.No.4.7.LOQ results of Nelarabine
                   
Calculation of S/N Ratio:
 Average Baseline Noise obtained from Blank = 48 µV
Signal Obtained from LOQ solution = 479µV
 S/N = 479/48 = 9.41
Discussion:  The S/N ratio was found to be within limits and it was calculated
as 9.41:1.
4.3.5. Robustness
Robustness  of  the  method  was  investigated  under  a  variety  of  conditions
including changes in the composition of the mobile phase, column temperature
and flow rate.% RSD of assay was calculated for each condition. 
In order to demonstrate the robustness of the method, the following optimized
conditions were slightly varied.
 5% in  mobile phase composition, 
 0.1 ml/min flow rate,
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The degree of reproducibility of the results obtained as a result of the above
small  deliberate  variations  in  the  method  parameters  has  proven  that  the
method is robust. 
a) Influence of Flow Variation
The robustness of the method was demonstrated by changing the flow rate to
+/-  0.1mL/min  of  specified flow rate  (1mL/min).  By injecting  the  replicate
injections of standard solution at a flow rate of 0.9mL/min and 1.1mL/min, it
was found that the system suitability parameters were passed. The %RSD of
peak  area,  tailing factor  and theoretical  plates  were  found  to  be  within  the
limits.  The chromatograms were shown in fig.No.4.34-4.35 and results  were
tabulated in table.No.4.9.
Fig.No.4.34. HPLC chromatogram with 0.9ml/min flowrate
Fig.No.4.35. HPLC chromatogram with 1.1ml/min flowrate
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                                    Table.No.4.9. Influence of Flow Variation
Parameter 0.9mL/min 1.1mL/min
Retention time 4.47 3.645
Area 2680365 %RSD 2122468 %RSD
2665296 0.98 2098529 0.86
Theoretical plates 4046.14 3818.45
b) Influence on variation in Mobile phase composition:
The  robustness  of  the  method  was  demonstrated  by  changing  the  organic
solvent ratio by +/-5%. By injecting the replicate injections of standard solution
with 5% change in organic phase ratio, it was found that the system suitability
parameters were passed. The %RSD of peak area, tailing factor and theoretical
plates  were found to be within the limits. The chromatograms were shown in
fig.No.4.36-4.37 and results were tabulated in table.No.4.10.
Fig.No.4.36. HPLC chromatogram with 5% more organic solvent
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                 Fig.No.4.37. HPLC chromatogram with 5% less organic solvent
                  
           Table.No.4.10. Influence on variation in Mobile phase composition
Parameter 5%  more organic
solvent
5% less organic solvent
Retention time 4.510 3.618
Area 2360411 %RSD 2300176 %RSD
2019654 1.02 2271134 0.99
Theoretical plates 4270.41 3809.67
Discussion: 
The robustness was tested by changing the flow rate, mobile phase composition
It was found that the system suitability parameters were within the acceptance
criteria. And the %RSD was found to be within limits (i.e., less than 2).
4.4. Forced degradation studies
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Intentional  degradation  was  attempted  to  stress  conditions  of  acidic,
basic/alkali, oxidative degradation and thermal treatment to evaluate the ability
of the proposed method to separate Nelarabine from its degradation products.
4.4.1. Acid degradation
                                      Fig.No.4.38.Chromatogram of acid degradation
 
S.no.
Peak name RT Area %Area USP plate
count
Tailing
factor
1 Peak 1 2.286 207808 4.21 653.39 1.49
2 Nelarabine 3.843 4736871 95.79 3839.22 1.24
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4.4.2. Alkali degradation
                                 Fig.No.4.39.Chromatogram of alkali degradation
4.4.3. Oxidative degradation
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S.No Peak name RT Area %Area USP
plate
count
Tailing
facor
1 Peak_1 2.593 1162327 69.17 590 1.75
2 Nelarabine 3.820 517916 30.38 1237.71 1.15
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                              Fig.No.4.40.Chromatogram of oxidative degradation
                       
4.4.4 Thermal degradation
Fig.No.4.41.Chromatogram of Thermal degradation
S.no. Peak name RT Area %Area USP
plate
count
Tailing
factor
1 Nelarabine 3.820 1271327 100 3990.08 1.27
4.4.5. Photolytic degradation
Fig.No.4.42.Chromatogram of Photolytic degradation
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S.no. Peak name RT Area %Area USP
plate 
Count
Tailing
factor
1 Peak 1 2.616 2996989 33.41 588.41 1.09
2 Nelarabine 3.841 7972363 66.59 4272.27 1.21
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S.no. Peak name RT Area %Area USP
plate
count
Tailing
factor
1 Nelarabine 3.850 2371327 100 39985.1 1.29
                              Table.No.4.11. Forced degradation summary of Nelarabine
Degradation type Experimental
condition
Storage
condition
Interpretation
Hydrolysis Acid degradation 
(1.5 N HCL) Refluxed at 60°c
for 2hrs
No peak 
interference
Base degradation 
(1.5 N NaOH)
No peak 
interference
Oxidative 30% peroxide Refluxed at 40°c
for 2hrs
No peak 
Interference
Thermal Heat chamber 80°c for 2hrs No peak 
Interference
Photolytic UV lamp 254nm for 2hrs No peak 
Interference
Conclusion:Forced  degradation  studies  of  Nelarabine  were  performed  at
different  stress  conditions.  The HPLC chromatograms of  degraded  products
showed no interference at the analyte peaks, hence the method was stability
indicating. It was also concluded that Nelarabine is more unstable at alkaline
pH.
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5. SUMMARY
A new method has been developed for the estimation of Nelarabine by RP-
HPLC method since it is a versatile tool for the qualitative and quantitative
analysis of drugs and pharmaceuticals.  
The chromatographic conditions were successfully developed for the separation
of  Nelarabine using Cosmicsil  Adze C-18 (150×4.6mm),  5µm column,  at  a
flow rate of 1.0mL/min, detection wave length of 266nm. The  mobile Phase
optimized  was  0.01%Trifluoro  acetic  acid  and  Acetonitrile  in  the  ratio  of
85:15% v/v.  The  instrument  used  was  WATERS HPLC auto  sampler.  The
retention times was found to be        3.83 mins. 
The developed method was validated in accordance with the ICH guidelines.
The results obtained were within the limits.
• Correlation  coefficient  value  for  calibration  plot  of  Nelarabine  was
0.999 and the regression equation was found to be Y = 104241x. 
• The  %RSD  for  precision  on  replicate  injection  and  intermediate
precision  was  0.88  and  0.82  respectively  which indicates  that  the
method was precise, robust and repeatable. 
• The  %  Recovery  was  within  limits  (98%-102%)  indicating  that  the
proposed method was highly accurate.  
• LOD value  was  3.08  and  LOQ value  was  9.41, which  indicates  the
sensitivity of the method. 
Forced degradation  studies  of  Nelarabine were performed at  different  stress
conditions.  The  HPLC  chromatograms  of  degraded  products  showed  no
interference at the analyte peaks, hence the method was stability indicating. It
was also concluded that Nelarabine is more unstable at alkaline pH.
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6. CONCLUSION
A  simple,  precise,  robust,  economical  and  accurate  stability  indicating  RP-HPLC
method was developed for the estimation of Nelarabine which  can be used for the
routine analysis of Nelarabine in API and Pharmaceutical dosage form.
Edaythangudy. G. S. Pillay College of Pharmacy Page 96
BIBLIOGRAPHY
                                     
1) Rashmin.B.Patel.  Analytical  methods development and validation play
important  roles  in  the  discovery,  development,  and
manufacture  of  pharmaceuticals,  from  website
http://www.pharmainfo.net/reviews/introduction-analytical-method
development-pharmaceutical-formulations/  accessed on 28/01/2013.
2) J.Mendham,R C Deney,  J D Barnes,M J K Thomas. Vogels Textbook
Of Quantitative Chemical Analysis. 6th edition. Pearson Education India:
2008.    147-159 P.
3) David G.Watson. Pharmaceutical Analysis. A text book for Pharmacy
students and Pharmaceutical Chemists. 2nd edition. Harcourt Publishers
Limited:1999. 267-311 P.
4) Lough  WJ,  Wainer  IW.  High  performance  liquid  chromatography.
Fundamental  principles  and practice.  London:  Blaclue  Academic  and
professional:1995.2-28 P.
5) Lindsay  S.  High  Performance  Liquid  Chromatography.  2nd  edition.
New York: John Wiley & Sons: 1991. 45-75 P.
6) Gurdeep R.chatwal, Sham K.Anand. Instrumental methods of chemical
analysis. 5th revised and enlarged edition. Himalaya  publishing house:
2007. 2.566-2.638 P.
7) H.  H.  Willard,  L.L.  Merritt,  J.A.  Dean,  F.A.  Settle.  Instrumental
Methods  of  Analysis.  7th edition.  New  Delhi:  CBS  publishers  and
Distributors: 1986.        593-600 P.
8) Michael  E,  Schartz  IS,  Krull.  Analytical  method   development  and
Validation. 3rd edition . London: John Wiley & sons : 2004. 25-46 P.
9) P.D.  Sethi.  High  performance  liquid  chromatography.  Quantitative
analysis  of  pharmaceutical  formulation.  1st  edition.  CBS publishers  :
2001. 1-30 P. 
10) B.k Sharma. Instrumental methods of chemical analysis. Introduction to
analytical  chemistry.  20th edition  .  Meerut:  Goel  publishing  house:
2001.1-4 P.
11)Rashmin.B.Patel.  Analytical  methods development and validation play
important  roles  in  the  discovery,  development,  and
manufacture  of  pharmaceuticals,  from  website
Edayathangudy G. S. Pillay College of Pharmacy Page 97
BIBLIOGRAPHY
http://www.pharmainfo.net/reviews/introduction-analytical-method-
development-pharmaceutical-formulations/ accessed on 28/01/2013.
12)Gurdeep R.chatwal, Sham K.Anand. Instrumental methods of chemical
analysis.  5th revised  and  enlarged  edition.Himalaya  publishing
house:2007. 2.570-2.579 P.
13)Ghulam  shabir.  HPLC  method  development  and  validation  in
pharmaceutical  analysis.  Hand  book  for  analytical  scientists.  Lap
Lambert academic    publishings: 2012. 31-46 P.
14)Ranjit Singh. HPLC method development and validation- an overview .J
Pharm Educ Res.  June 2013, 4(1).26-33.
15)Oona MC Polin .Validation of analytical  methods for pharmaceutical
analysis. UK: Mourne training services pubisher : 2009.17-67 P.
16)ICH harmonised tripartite guideline validation of  analytical procedures:
Text  and  methodology,  Q2(R1)  ,Current  Step  4 version:  Parent
Guideline dated 27 October 1994.
17)Patel  Riddhiben  M.  Stability  Indicating  HPLC  method-  A  Review.
IRJP .2011,    2(5),79-87.
18)Nelarabine  injection   drug  profile  and  pharmacokinetic  information,
from  website  http://www.druginformation.com/RxDrugs/N/Nelarabine
Injection.htm accessed on 08/01/2013.
19)Martin  H.  Cohen,M.D.  John  R.  Johnson,  M.D.Tristan  Massie,
Ph.D.FDA.  Arranon  (Nelarabine)  ODAC Briefing  Document  Clinical
and Statistical, September 14, 2005 Meeting, NDA 21- 877, 1-56 P.
20)Huang  qiaoqiao,et  al.  Determination  of  Nelarabine  by  Non-aqueous
titration method.  Journal  of  china pharmaceutical  university.2012, 04,
27-35.
21)Yoshiyuki  Minamide*,  Harue  Igarashi,  Akira  Wakamatsu,  Shinobu
Kudoh.Journal  of  analytical  andbioanalytical.  A  Standard  Addition
Method Utilizing an Endogenous Substance as an Internal Standard for
Quantitating  Arabinofuranosylguanosine  5’-Triphosphate  in  Human
Peripheral  Blood  Mononuclear  Cells  by  Lc-Ms/Ms. Journal  of
Analytical & Bioanalytical Techniques:Special. 2012, 3(5),1-5. 
Edayathangudy G. S. Pillay College of Pharmacy Page 98
BIBLIOGRAPHY
22)Jeanette kaiser Pharm D,Professor Irene Kramer PhD. Physicochemical
stability of  nelarabine infusion solution in  EVA infusion bags. EJHP
Science. 2011,        17(1), 7-12.
23)C.Nageshwar  Reddy,P.Reddy Prasad,N.Y.Sreedhar  .  Determination  of
nelarabine  in  pharmaceutical  formulations  and  urine  samples  by
adsorptive stripping voltametry. IJPRIF .2011, 3(2),1125-1131.
24)Takahero  yamauchi,Rie  nishi,  Kzuhiro  kitazumi,Tsuyoshi  nakano,
Takanori ueda. A new HPLC method for determines low production of
arabinosyl  guanine triphosphate,an active metabolite of nelarabine  in
adult T-cell leukemia cells. Oncology reports. 2010 ,23, 499-504.
25)Berg SL, Brueckner C, Nuchtern JG, Dauser R, McGuffey L, Blaney
SM. Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in
nonhuman  primates.  Cancer  Chemother  Pharmacol.2007  May,
59(6),743-747.
26)Carlos O.Rodriguez Jr.,William Plunkett,Melanie T.Paff,Min Du,Billie
Nowak,Prameen Ramakrishna,Michael  J.Keating,Varsha Gandhi.  High
performance  liquid  chromatography  method  for  determination  and
quantitation  of  arabinosulguanine  triphosphate  and  fludarabine
triphosphate  in  human  cells. Journal  of  chromatography  B.  2000  ,
745(2), 421-430.
Edayathangudy G. S. Pillay College of Pharmacy Page 99
